We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
World Heart Corp., a former Ottawa-based medical device company whose stock trades on the Toronto market, is reporting a fourth-quarter loss of $22 million US after a huge writedown.
A new laser zaps through blockages to ease the pain of peripheral artery disease and appears to dramatically reduce the risk of amputation in people with diabetes.
Ranbaxy Laboratories Ltd on Tuesday announced that its wholly owned subsidiary, Ranbaxy Pharmaceuticals Inc. (RPI), USA, has purchased patents, trademarks, and automated manufacturing equipment for Senetek PLC's proprietary disposable autoinjector for self administration of parenteral drugs, including epinephrine for emergency treatment of anaphylactic shock from peanut and other allergies.
Revenues of MicroElectroMechanical Systems (MEMS) in biotechnology accounted for nearly $1 billion in 2005, says a new report published by Bourne Research. "The Bourne Report -- Medical Device Quarterly" outlines the use of (MEMS) and nanotechnology in medicine and covers next-generation technologies, products, applications and trends.
St. Jude Medical has announced FDA approval of its next-generation
vascular closure device, the Angio-Seal VIP. The device has also received CE Mark approval in Europe.
If not for the bedside monitor that tracks the condition of her heart device and her health, Marjorie Moncrief would never have left Oakdale to spend the winter with her husband in Arizona.